Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 1Phase 2 Interventional

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

ClinicalTrials.gov ID: NCT05197270

Public ClinicalTrials.gov record NCT05197270. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2 Dose-Escalation and Randomized, Controlled, Masked Expansion Trial of Intravitreal 4D-150 Gene Therapy in Adults With Neovascular (Wet) Age-Related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment. Substudies will evaluate the safety and tolerability of 4D-150 contralateral eye dosing and characterize vector shedding.

Study identification

NCT ID
NCT05197270
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
4D Molecular Therapeutics
Industry
Enrollment
215 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 8, 2021
Primary completion
Feb 28, 2027
Completion
Dec 31, 2030
Last update posted
Aug 20, 2026

2021 – 2031

United States locations

U.S. sites
25
U.S. states
16
U.S. cities
24
Facility City State ZIP Site status
Barnet Delaney Perkins Eye Center Phoenix Arizona 85016 Recruiting
California Retina Consultants Oxnard California 93036 Recruiting
Retinal Consultants Medical Group Sacramento California 95841 Recruiting
Colorado Retina Associates Lakewood Colorado 80288 Recruiting
Rand Eye Institute Deerfield Beach Florida 33064 Suspended
Retina Group of Florida Fort Lauderdale Florida 33308 Recruiting
Retina Vitreous Consultants, LLP DBA Retina Group of Florida Fort Lauderdale Florida 33308 Active, not recruiting
Vitreo Retinal Associates Gainesville Florida 32607 Recruiting
Florida Eye Associates Melbourne Florida 32901 Recruiting
Retinal Specialty Institute Pensacola Florida 32503 Recruiting
Retina Vitreous Associates of Florida Tampa Florida 33607 Recruiting
University Retina and Macula Associates Oak Forest Illinois 60452 Recruiting
Retina Partners Midwest Carmel Indiana 46290 Recruiting
Cumberland Valley Retina Consultants Hagerstown Maryland 21740 Recruiting
Ophthalmic Consultants of Boston & Boston Eye Surgery and Laser Center Boston Massachusetts 02114 Recruiting
Sierra Eye Associates Reno Nevada 89502 Recruiting
Western Carolina Retinal Associates Asheville North Carolina 28803 Withdrawn
Verum Research, LLC Eugene Oregon 97401 Recruiting
Mid Atlantic Retina Bethlehem Pennsylvania 18017 Recruiting
Palmetto Retina Center, LLC West Columbia South Carolina 29169 Recruiting
Tennessee Retina Nashville Tennessee 37203 Recruiting
Austin Clinical Research Austin Texas 78750 Recruiting
Valley Retina Institute, PA McAllen Texas 78503 Recruiting
Retina Consultants of Texas The Woodlands Texas 77384 Withdrawn
Pacific Northwest Retina LLC Bellevue Washington 98004 Withdrawn

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05197270, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 20, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05197270 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →